Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Firoz A Jaipuri

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Organic & Biomolecular Chemistry|July 18, 2008
Toward solution-phase automated iterative synthesis: fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomersFiroz A Jaipuri, Nicola L Pohl
Journal of the American Chemical Society|January 20, 2005
One-step synthesis of labeled sugar nucleotides for protein O-GlcNAc modification studies by chemical function analysis of an archaeal proteinRahman M Mizanur, Firoz A Jaipuri, Nicola L Pohl
Journal of the American Chemical Society|September 22, 2005
Fluorous-based carbohydrate microarraysKwang-Seuk Ko, Firoz A Jaipuri, Nicola L Pohl
Organic Letters|August 15, 2012
Synthesis of 6,6'-binaphthopyran-2-one natural products: pigmentosin A, talaroderxines A and BCharles I Grove, Michael J Di Maso, Firoz A Jaipuri, et al.
Journal of Lipid Research|May 30, 2007
Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BIThomas J F Nieland, Jared T Shaw, Firoz A Jaipuri, et al.
Biochemistry|December 11, 2007
Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activityThomas J F Nieland, Jared T Shaw, Firoz A Jaipuri, et al.
Journal of Medicinal Chemistry|July 3, 2019
Discovery of Clinical Candidate (1<i>R</i>,4<i>r</i>)-4-((<i>R</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1Sanjeev Kumar, Jesse P Waldo, Firoz A Jaipuri, et al.
European Journal of Medicinal Chemistry|May 19, 2020
Discovery of indoximod prodrugs and characterization of clinical candidate NLG802Sanjeev Kumar, Firoz A Jaipuri, Jesse P Waldo, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase InhibitorsBrendan T Parr, Richard Pastor, Benjamin D Sellers, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Organic & Biomolecular Chemistry|July 18, 2008
Toward solution-phase automated iterative synthesis: fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomersFiroz A Jaipuri, Nicola L Pohl
Journal of the American Chemical Society|January 20, 2005
One-step synthesis of labeled sugar nucleotides for protein O-GlcNAc modification studies by chemical function analysis of an archaeal proteinRahman M Mizanur, Firoz A Jaipuri, Nicola L Pohl
Journal of the American Chemical Society|September 22, 2005
Fluorous-based carbohydrate microarraysKwang-Seuk Ko, Firoz A Jaipuri, Nicola L Pohl
Organic Letters|August 15, 2012
Synthesis of 6,6'-binaphthopyran-2-one natural products: pigmentosin A, talaroderxines A and BCharles I Grove, Michael J Di Maso, Firoz A Jaipuri, et al.
Journal of Lipid Research|May 30, 2007
Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BIThomas J F Nieland, Jared T Shaw, Firoz A Jaipuri, et al.
Biochemistry|December 11, 2007
Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activityThomas J F Nieland, Jared T Shaw, Firoz A Jaipuri, et al.
Journal of Medicinal Chemistry|July 3, 2019
Discovery of Clinical Candidate (1<i>R</i>,4<i>r</i>)-4-((<i>R</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1Sanjeev Kumar, Jesse P Waldo, Firoz A Jaipuri, et al.
European Journal of Medicinal Chemistry|May 19, 2020
Discovery of indoximod prodrugs and characterization of clinical candidate NLG802Sanjeev Kumar, Firoz A Jaipuri, Jesse P Waldo, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase InhibitorsBrendan T Parr, Richard Pastor, Benjamin D Sellers, et al.
Pageof 1